JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Solitary benign schwannomas in major nerve systems of the head and neck.

Solitary schwannomas of the head and neck are uncommon tumors arising from any cranial or autonomic nerve. Twenty-five percent to 45% of extracranial schwannomas occur in the head and neck. A total of 28 consecutive patients treated be tween January 2000 and August 2006 for solitary schwannomas in different major nerves of the head and neck were included in this study. Most affected trunks were cranial nerves in 14 patients (50%), cervical sympathetic chain in 7 (25%), and brachial plexus in 7 (25%). The most common sign was an isolated well-demarcated lesion placement at the lateral aspect of the neck for those tumors arising from vagus, lingual, and sympathetic nerves. Total resection with nerve conservation was the treatment of choice for these tumors. In 26 patients (94%), no functional sequels were detected; in 2 other patients (6%), Horner syndrome was a consequence of sympathetic chain resection. No relapse was detected in all 28 patients.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app